Addressing Immunogenicity for Implantable Drug-delivery Devices and Long-acting Injectables, Including Pharmacokinetic and Pharmacodynamic Correlations
用户aKgJC6g3RnhA
22小时前
22
10
待确认
帖子自动结束时间: 2025-05-13 09:40:42
1. 请及时下载文件确认是否正确, 系统将在 2025-05-15 10:55:45 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
J Matriano
2021
books.rsc.org
… , PD, and PK of ITCA 650 in patients with T2D was performed. … µg per day of the ITCA 650 implant placed subcutaneously for … of ITCA 650 in subjects with T2D treated for up to 48 weeks. …